SP
BravenNow
Vinay Prasad
πŸ‘€ Person

Vinay Prasad

American hematologist-oncologist

πŸ“Š Rating

2 news mentions Β· πŸ‘ 0 likes Β· πŸ‘Ž 0 dislikes

πŸ’‘ Information Card

# Vinay Prasad


Who / What

Vinay Prasad is an American hematologist-oncologist and health researcher. He holds a leadership position at a major U.S. regulatory agency and is a professor and author focused on medical evidence and policy.


Background & History

Vinay Prasad, whose full name is Vinayak Kashyap Prasad, built his career as a professor of epidemiology and biostatistics at the University of California, San Francisco (UCSF). He gained prominence through his research and writing, authoring influential books on medical practices. A key milestone in his career was his appointment in May 2025 to a directorship at a U.S. Food and Drug Administration (FDA) center.


Why Notable

He is notable for his significant contributions to the critique of medical evidence and practices through his research and publications like *Ending Medical Reversal* and *Malignant*. His role as a professor at UCSF established him as a leading voice in epidemiology. His appointment as director of the FDA's Center for Biologics Evaluation and Research marks a major achievement, placing him in a position to influence national health policy and drug regulation.


In the News

Vinay Prasad is currently relevant due to his appointment in May 2025 as director of the FDA's Center for Biologics Evaluation and Research. This development matters as it places him in a key regulatory role overseeing biologics, which is a critical area of medicine and public health. His leadership is likely to shape FDA policies on complex treatments like vaccines and gene therapies.


Key Facts

  • **Type:** person
  • **Also known as:** Vinayak Kashyap Prasad
  • **Founded / Born:** Information not provided in source data.
  • **Key dates:**
  • 2015: Publication of *Ending Medical Reversal*
  • 2020: Publication of *Malignant*
  • May 2025: Appointed director of the Center for Biologics Evaluation and Research at the FDA
  • **Geography:** United States
  • **Affiliation:** U.S. Food and Drug Administration (FDA), University of California, San Francisco (UCSF), field of Hematology-Oncology and Health Research

  • Links

  • [Wikipedia](https://en.wikipedia.org/wiki/Vinay_Prasad)
  • Sources

    πŸ“Œ Topics

    • Regulatory Change (1)
    • Public Health (1)
    • FDA Leadership (1)
    • Vaccine Regulation (1)
    • Government Departures (1)

    🏷️ Keywords

    FDA (2) Β· Vinay Prasad (2) Β· vaccines (1) Β· departure (1) Β· regulator (1) Β· leadership (1) Β· April (1) Β· Vaccines (1) Β· Biologics Evaluation (1) Β· Departure (1) Β· Controversial decisions (1) Β· UC San Francisco (1)

    πŸ“– Key Information

    Vinayak "Vinay" Kashyap Prasad is an American hematologist-oncologist and health researcher who has served as the director of the Center for Biologics Evaluation and Research, a branch of the U.S. Food and Drug Administration (FDA), since May 2025. He was a professor of epidemiology and biostatistics at the University of California, San Francisco (UCSF), and is the author of the books Ending Medical Reversal (2015) and Malignant (2020).

    πŸ“° Related News (2)

    πŸ”— Entity Intersection Graph

    Food and Drug Administration(2)April(1)Departure(1)Vaccine(1)Vinay Prasad

    People and organizations frequently mentioned alongside Vinay Prasad:

    πŸ”— External Links